Treprostinil 200 mg/20mL (Treprostinil INJECTION, SOLUTION) 200 mg/20mL

Treprostinil 200 mg/20mL is a medication used for specific medical conditions. This injection solution is designed for intravenous or subcutaneous administration, offering a versatile treatment option.

Strength

200 mg/20mL

Pack Size

1 VIAL, MULTI-DOSE in 1 CARTON (0703-0696-01) / 20 mL in 1 VIAL, MULTI-DOSE

Manufacturer / TM Owner

Teva Parenteral Medicines, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Treprostinil is primarily used to manage certain cardiovascular and pulmonary conditions. It is often prescribed for conditions that require vasodilation or improved blood flow. Patients may wonder, 'What is Treprostinil used for?' This medication is typically utilized in scenarios where maintaining vascular health is crucial.

Side Effects

Treprostinil may cause common effects such as headache, nausea, or injection site reactions. Some users might experience dizziness or flushing. These effects can vary depending on individual tolerance and the specific condition being treated.

Precautions & Warnings

Handling Treprostinil requires careful attention to dosage and administration guidelines. It is important to follow the prescribed protocol to minimize potential risks. Always consult a healthcare provider for personalized advice on using this medication.

Avoid Interactions

Treprostinil may interact with other medications, including those that affect blood pressure or heart rate. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also influence its effects.

Frequently Asked Questions

Treprostinil is used to manage certain cardiovascular and pulmonary conditions by promoting vasodilation and improving blood flow.

Treprostinil is administered via intravenous or subcutaneous injection, following specific medical guidelines.

Common side effects may include headache, nausea, dizziness, and injection site reactions.

Treprostinil may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

Treprostinil is available in various strengths, including 200 mg/20mL, to cater to different medical needs.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.